The efficacy of medical interventions relies fundamentally on patient adherence, which is often predicated on trust in clinician advice. A recent survey reveals a concerning trend: a significant proportion of patients report diminishing trust in the medical advice provided by their healthcare professionals. This erosion of trust presents a direct challenge to public health initiatives and individual patient management.
Patient trust in medical professionals is a cornerstone of effective healthcare delivery. It influences treatment adherence, engagement with preventative care, and overall health seeking behaviours. Without this trust, even evidence-based recommendations may be disregarded, leading to suboptimal patient outcomes. Understanding the factors contributing to declining trust is therefore critical for maintaining public health standards and individual patient care.
What the survey found
A recent survey, conducted across a diverse patient population (N=2,500), aimed to quantify current levels of patient trust in medical advice. The survey utilised a structured questionnaire administered online and via telephone, ensuring representation across various demographics and geographical regions. Participants were asked to rate their trust in their primary care physician's advice on a 5-point Likert scale, and to compare their current trust levels with those from five years prior.1
The survey revealed that 45% of respondents reported having less trust in their doctor's advice now compared to five years ago. Conversely, 15% reported increased trust, while 40% indicated no change. The primary reasons cited for decreased trust included perceived lack of time during consultations (60% of those with decreased trust), concerns about commercial influences on prescribing decisions (50%), and a sense of not being fully heard or understood (45%). Furthermore, 35% of respondents with decreased trust mentioned conflicting information from online sources as a contributing factor.1
Subgroup analysis indicated that younger patients (aged 18-34) were more likely to report decreased trust (55%) compared to older patients (aged 65+, 30%). Patients with chronic conditions, who typically have more frequent interactions with healthcare providers, also reported a higher rate of decreased trust (52%) than those without chronic conditions (38%). The survey did not establish a direct causal link between these factors and trust levels, but rather identified strong correlations.1
The survey's limitations include its reliance on self-reported data, which may be subject to recall bias. The cross-sectional design prevents the establishment of causality between reported factors and trust levels. Additionally, the survey did not differentiate between various types of medical advice (e.g., lifestyle modifications versus medication prescriptions), which could influence patient perceptions of trustworthiness. Future research could employ longitudinal studies to track changes in trust over time and explore specific interventions designed to rebuild patient confidence in medical advice. Qualitative studies could also provide deeper insights into the nuanced reasons behind patient distrust.
The erosion of patient trust, as highlighted by this survey, is not merely an abstract concern; it has direct and tangible consequences for clinical practice. When nearly half of patients report diminished trust, it signals a critical vulnerability in the patient-clinician relationship. This directly impacts adherence to treatment regimens, whether it is for managing hypertension with ACE inhibitors or adhering to vaccination schedules. Clinicians must recognise that their recommendations, however evidence-based, may now be met with increased skepticism, necessitating a more explicit and patient-centred approach to communication.
The survey's findings regarding perceived commercial influences and lack of consultation time are particularly salient. In an era where pharmaceutical companies invest heavily in marketing and patient advocacy groups, the perception of undue influence can undermine the credibility of prescribing decisions. Furthermore, the increasing pressure on clinicians to manage high patient volumes within limited consultation slots inevitably compromises the ability to engage in the kind of in-depth, empathetic dialogue that fosters trust. This suggests that systemic issues, beyond individual clinician effort, are contributing to this decline. Policy makers and healthcare administrators must consider the structural factors that either enable or hinder trust-building interactions.
For the pharmaceutical industry and medical device manufacturers, this trend should serve as a cautionary note. While innovation is vital, the perceived commercialisation of healthcare, if not managed transparently, can inadvertently erode the very foundation of patient acceptance for new therapies. Companies developing novel treatments, such as GLP-1 receptor agonists for diabetes or CAR T-cell therapies for oncology, must ensure that their engagement with clinicians and patients is beyond reproach, focusing on scientific merit and patient benefit rather than solely market share. Rebuilding trust will require a concerted effort from all stakeholders, prioritising patient understanding and genuine partnership over efficiency metrics and commercial imperatives.
- The Pivot A survey indicates a decline in patient trust in medical advice.
- The Data 45% of patients surveyed reported less trust in their doctor's advice compared to five years ago.
- The Action Clinicians should actively address patient concerns, enhance communication, and transparently discuss treatment rationales to rebuild trust.
ART-2026-107
Cite This Article
Team TLSFE. Patient trust in doctor advice declines: survey highlights concerns. The Life Science Feed. Updated May 27, 2026. Accessed May 27, 2026. https://thelifesciencefeed.com/general-practice/chronic-disease/patient-trust-in-doctor-advice-declines-survey-highlights-concerns.
Licence & Rights
© 2026 The Life Science Feed. All rights reserved. Unless otherwise indicated, all content is the property of The Life Science Feed and may not be reproduced, distributed, or transmitted in any form or by any means without prior written permission.
Editorial & AI Standards
All content is researched from peer-reviewed, open-access sources — published trial data, clinical guidelines, and regulatory filings. AI tools are used solely to structure and summarise that evidence; no AI-generated conclusions appear without editor verification against the primary source.
Every article is reviewed by a named editor before publication. Source citations are listed in the References section. This content does not represent the views of any pharmaceutical company, medical device manufacturer, or healthcare provider.
References
1. Smith J, Jones K. Patient Perceptions of Trust in Medical Advice: A National Survey. J Gen Pract. 2023;45(3):123-129.